Relx Plc (NYSE:RELX) Shares Purchased by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC grew its position in shares of Relx Plc (NYSE:RELX) by 11.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,761 shares of the technology company’s stock after acquiring an additional 1,756 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Relx were worth $807,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Private Trust Co. NA grew its position in Relx by 19.2% in the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company’s stock worth $56,000 after purchasing an additional 199 shares during the last quarter. Sage Mountain Advisors LLC increased its position in Relx by 5.1% in the 4th quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company’s stock valued at $240,000 after acquiring an additional 258 shares during the period. Peapack Gladstone Financial Corp raised its stake in Relx by 5.7% during the 3rd quarter. Peapack Gladstone Financial Corp now owns 4,924 shares of the technology company’s stock valued at $234,000 after acquiring an additional 267 shares in the last quarter. EWA LLC boosted its position in Relx by 5.2% during the 3rd quarter. EWA LLC now owns 5,501 shares of the technology company’s stock worth $253,000 after acquiring an additional 272 shares during the period. Finally, Marks Group Wealth Management Inc grew its stake in shares of Relx by 1.3% in the fourth quarter. Marks Group Wealth Management Inc now owns 26,196 shares of the technology company’s stock worth $1,190,000 after purchasing an additional 325 shares in the last quarter. Institutional investors and hedge funds own 15.02% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on RELX shares. Redburn Atlantic assumed coverage on shares of Relx in a report on Wednesday, January 8th. They issued a “buy” rating for the company. StockNews.com lowered shares of Relx from a “buy” rating to a “hold” rating in a research note on Tuesday, March 4th. Barclays upgraded shares of Relx from an “equal weight” rating to an “overweight” rating in a research note on Friday, March 14th. Finally, The Goldman Sachs Group initiated coverage on Relx in a report on Wednesday, March 26th. They set a “buy” rating on the stock. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy”.

Relx Stock Performance

Relx stock opened at $50.93 on Thursday. Relx Plc has a fifty-two week low of $40.25 and a fifty-two week high of $51.99. The firm’s 50 day simple moving average is $49.59 and its 200-day simple moving average is $47.89. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. The company has a market cap of $94.53 billion, a P/E ratio of 27.38, a price-to-earnings-growth ratio of 2.73 and a beta of 0.84.

Relx Increases Dividend

The company also recently announced a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be paid a dividend of $0.5586 per share. This is an increase from Relx’s previous semi-annual dividend of $0.23. This represents a yield of 1.6%. The ex-dividend date is Friday, May 9th. Relx’s payout ratio is 59.68%.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.